[Skip to Content]
[Skip to Content Landing]
Multiple Discipline Research Forum
March 7, 1964

Some Effects of Urease Immunity in Hepatic Insufficiency

Author Affiliations


From the departments of pharmacology and medicine, University of Chicago.; Dr. Thomson is presently in the Department of Medicine, University of Illinois and Presbyterian-St. Lukes Hospital.

JAMA. 1964;187(10):727-728. doi:10.1001/jama.1964.03060230055014

THE CURRENT THERAPY of hepatoencephalopathy has consisted principally of a regimen of dietary protein restriction and antibiotics.1,2 In these studies we have attempted to invoke an immune mechanism to inhibit bacterial urease present in the gastrointestinal tract and thus decrease the quantity of ammonia transported to the liver for detoxification.

Administration of ammonium salts or of substances which can be enzymatically broken down to ammonia will produce hepatic coma in patients with liver disease.3-5 Proteins and their derivatives exposed to bacterial enzymes in the gastrointestinal tract are a constant source of ammonia.6-8 Under normal circumstances ammonia so produced is carried via the portal circulation to the liver where it is converted to urea and is thereby diverted from the systemic circulation.9,10 Many patients with hepatic coma have an elevated concentration of ammonia in the blood.11,12 This blood ammonium concentration represents a balance between production in

First Page Preview View Large
First page PDF preview
First page PDF preview